FATE insider trading

See Fate Therapeutics (FATE) insider purchases and sales from SEC Form 4, with trade dates, shares, prices, values and links to the filings.

Insider trades

InsiderRoleTradeTradedFiledSharesPriceValueSource
Adawi KamalChief Financial OfficerSellNov 3, 2026Nov 4, 20266,582$2.05$13.52KFiling
TAHL CINDYSee RemarksSellAug 4, 2026Aug 5, 202638,800$2.46$95.45KFiling
Valamehr BahramPresident and CEO, DirectorSellAug 4, 2026Aug 5, 202643,947$2.46$108.11KFiling
TAHL CINDYSee RemarksSellMay 20, 2026May 21, 202625,590$1.88$48.08KFiling
Valamehr BahramPresident and CEO, DirectorSellMay 20, 2026May 21, 202628,946$1.88$54.48KFiling
TAHL CINDYSee RemarksSellJan 9, 2026Jan 12, 202610,589$1.06$11.28KFiling
Valamehr BahramPresident and CEO, DirectorSellJan 9, 2026Jan 12, 20265,190$1.07$5.56KFiling
TAHL CINDYSee RemarksSellAug 4, 2025Aug 5, 20259,037$1.06$9.57KFiling
Valamehr BahramPresident and CEO, DirectorSellAug 4, 2025Aug 5, 202514,466$1.06$15.40KFiling
Bressi Jerome CharlesSee RemarksSellJan 10, 2025Jan 13, 20255,980$1.55$9.27KFiling
TAHL CINDYSee RemarksSellJan 10, 2025Jan 13, 20255,654$1.55$8.76KFiling
Valamehr BahramPresident and CEO, DirectorSellJan 10, 2025Jan 13, 20258,705$1.54$13.41KFiling
Redmile Group, LLCDirector, 10% ownerSellDec 20, 2024Dec 26, 2024341,633$1.68$573.94KFiling
Redmile Group, LLCDirector, 10% ownerBuyDec 20, 2024Dec 26, 2024397,964$1.68$668.58KFiling